Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,263
in 2 filings

Net −$22,263. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-12-29 CHESS ROBERT Director Sale −29,500 $15.34 $453K 260,623
2014-12-29 CHESS ROBERT Director Exercise or conversion · Stock Option −29,500 0
2014-12-22 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion +5,000 $11.38 $57K 7,999
2014-12-22 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −5,000 $15.56 $78K 2,999
2014-12-22 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion · Stock Option −5,000 0
2014-12-09 ROBIN HOWARD W President & CEO Grant or award · Stock Option +225,000 225,000
2014-12-09 ROBIN HOWARD W President & CEO Grant or award · Stock Option +225,000 225,000
2014-12-09 Nicholson John SVP & Chief Financial Officer Grant or award · Stock Option +87,500 87,500
2014-12-09 Nicholson John SVP & Chief Financial Officer Grant or award · Stock Option +87,500 87,500
2014-12-09 Labrucherie Gil M SVP & General Counsel Grant or award · Stock Option +87,500 87,500
2014-12-09 Labrucherie Gil M SVP & General Counsel Grant or award · Stock Option +87,500 87,500
2014-12-09 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award · Stock Option +50,000 50,000
2014-12-09 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award · Stock Option +50,000 50,000
2014-12-09 Gergel Ivan P. SVP & Chief Medical Officer Grant or award · Stock Option +50,000 50,000
2014-12-09 Gergel Ivan P. SVP & Chief Medical Officer Grant or award · Stock Option +50,000 50,000
2014-12-09 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Stock Option +50,000 50,000
2014-12-09 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Stock Option +50,000 50,000
2014-12-09 Thomsen Jillian B. SVP & Chief Accounting Officer Grant or award · Stock Option +50,000 50,000
2014-12-09 Thomsen Jillian B. SVP & Chief Accounting Officer Grant or award · Stock Option +50,000 50,000
2014-12-01 Labrucherie Gil M SVP & General Counsel Exercise or conversion +30,000 $4.65 $140K 34,251

Page 64 of 69 · 1,361 trades